BSE filing, BSE: 544811. Summary written from the filing by ALFA Finder's alert engine.
Kratikal Tech Ltd: key numbers
- Share price
- ₹155.00
- Market cap
- ₹172.1 Cr
- Revenue (annual)
- ₹36.72 Cr
- Net profit (annual)
- ₹6.14 Cr
- P/E (TTM)
- 28.0×Sector 22.9×
- Promoter holding
- 53.40%
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kratikal Tech Ltd
All →Kratikal Tech Other Announcement
Kratikal Tech Ltd has filed its quarterly shareholding pattern as per SEBI regulations. This is a periodic compliance disclosure with no material event impact.
Kratikal Tech Merger & Restructuring Worth ₹0.1 Cr
Kratikal Tech Ltd incorporated a wholly-owned subsidiary, Kratikal AI Inc., in Delaware, USA, as an SPV for cybersecurity operations with a USD 10,000 investment.
- Value
- ₹0.10 Cr
Kratikal Tech Other Announcement
Kratikal Tech Limited has appointed GoIndia Advisors LLP to provide investor relations management services, effective October 08, 2026, to strengthen its investor engagement framework.
Kratikal Tech Management Change
Kratikal Tech Limited has appointed Mittal V Kothari & Associates as Secretarial Auditor and MSMK & Co. as Internal Auditor, each for a 12-month term.
Kratikal Tech Merger & Restructuring
Kratikal Tech's board approved incorporating a wholly owned US subsidiary for cybersecurity and information security services. The Delaware-based entity is subject to regulatory approval.
Kratikal Tech Management Change
Kratikal Tech Limited has appointed Mr. Dip Jung Thapa as an Executive Director for a five-year term effective August 31, 2026. He currently serves as the Promoter and COO.
- Execution
- 60 months
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date